Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry

G. MacGregor, T. Hilliard, M. Imrie, J. A. Innes, A. C. Boyd, E. Alton, J. Davies, A. Bush, D. Porteous, A. P. Greening (Edinburgh, London, United Kingdom)

Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems
Session: Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems
Session type: Oral Presentation
Number: 1355
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. MacGregor, T. Hilliard, M. Imrie, J. A. Innes, A. C. Boyd, E. Alton, J. Davies, A. Bush, D. Porteous, A. P. Greening (Edinburgh, London, United Kingdom). Improved biomarkers of cystic fibrosis lung disease in bronchoalveolar lavage fluid identified using SELDI-TOF mass spectrometry. Eur Respir J 2004; 24: Suppl. 48, 1355

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005


Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


Pulmonary transplantation and bronchiolitis obliterans syndrome: characterisation of diagnostic biomarkers in bronchioloalveolar lavage fluid by SELDI-TOF proteomic analysis
Source: Annual Congress 2009 - Bronchiolitis obliterans syndrome after lung transplantation: pathophysiology and treatment options
Year: 2009



Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF)
Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases
Year: 2006


Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach
Source: Eur Respir J 2003; 21: 414-420
Year: 2003



Early detection of lung disease in cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007



Interstitial lung disease profiling by mean of broncho-alveolar lavage
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Altered expression of bronchoalveolar lavage fluid proteins in sarcoidosis: A proteomics approach
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003

Transcriptome analysis in endobronchial epithelial lining fluid compared to bronchoalveolar lavage in idiopathic pulmonary fibrosis
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


Cytokine profiles of bronchoalveolar lavage fluid in patients with combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012


Association between lobe specific bronchoalveolar lavage fluid metabolites and structural lung disease in young children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015

SELDI-TOF biomarkers signatures for cystic fibrosis, asthma and COPD
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009


Proteomic profiling of peripheral blood and bronchoalveolar lavage fluid in interstitial lung diseases: an explorative study
Source: ERJ Open Res, 7 (1) 00489-2020; 10.1183/23120541.00489-2020
Year: 2021



The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010



Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis
Source: Eur Respir J 2014; 43: 610-626
Year: 2013



Correlation between imaging fibrosis severity and bronchoalveolar lavage pattern in interstitial lung disease
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019

Surfactant protein A and other bronchoalveolar lavage fluid proteins are altered in cystic fibrosis
Source: Eur Respir J 2001; 17: 716-722
Year: 2001



The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
Year: 2009

ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease
Source: Eur Respir J 2001; 18: Suppl. 33, 538s
Year: 2001

Interlobar differences in bronchoalveolar lavage fluid from children with cystic fibrosis
Source: Eur Respir J 2001; 17: 281-286
Year: 2001